Oyster Point Pharma, Inc. Inventory Write-down
Oyster Point Pharma, Inc. reported Inventory Write-down of -$73.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2022-11-10
- Oyster Point Pharma, Inc. inventory write-down for the quarter ending 2022-09-30 was -$6.00K.
- Oyster Point Pharma, Inc. inventory write-down for the quarter ending 2021-09-30 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month |
|---|---|---|---|
| 2022-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$73.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$67.00K 10-Q · filed 2022-08-11 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |